PT Biometrik Riset Indonesia Appointed as CRO for Uremic Clearance Granules (UCG) Clinical Trial, Marking Milestone in Indonesia–China Research Collaboration
Jakarta, October 15, 2026 – PT Biometrik Riset Indonesia, an independent Contract Research Organization (CRO) specializing in clinical research and Bioequivalence (BE) studies, plays a key role in overseeing the clinical trial of Uremic Clearance Granules (UCG), a Traditional Chinese Medicine (TCM) product, officially launched at RSPAD Gatot Soebroto Puskesad, Jakarta, on October 15, 2026.
This clinical trial represents an important milestone in international clinical research collaboration between Indonesia and China, bringing together PT Intrada Subur Abadi (Indonesia), Consun Pharmaceutical...